Novel peptide ligands of leukocyte integrins

A technology for integrin and leukocytes, applied to peptide/protein components, medical preparations containing active ingredients, peptides, etc., can solve problems that hinder the modeling of small molecule inhibitors

Inactive Publication Date: 2006-11-08
CTT CANCER TARGETING TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Modeling of such small molecule inhibitors is hampered by the macromolecular peptide ligands disclosed so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel peptide ligands of leukocyte integrins
  • Novel peptide ligands of leukocyte integrins
  • Novel peptide ligands of leukocyte integrins

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Embodiment 1, phage display

[0054] Alpha was purified from buffy coats obtained from the Finnish Red Cross Blood Transfusion Service by antibody affinity chromatography as previously described. M beta 2 Integrin (Li et al., 1995), Integrin Tris-buffered saline / 1 mM MnCl 2 After dilution, the microtiter wells were coated and left overnight at 4°C, with 1 μg per well for the first biopanning, and 100ng, 10ng, and 1ng for subsequent pannings, respectively. The sample wells were blocked with TBS containing 5% BSA at 22° C. for 1 hour, and then washed five times with TBS. Basically use CX in the same way as previously described 7 C and CX 9 C phage peptide libraries were biopanned (Koivunen et al., 1994). We modified the library construct to convert single-stranded DNA encoding degenerate sequences to double-stranded by 5 cycles of PCR using only the reverse primer followed by 11 cycles using both forward and reverse primers form. A total of 6 μg of double-stranded ...

Embodiment 2

[0072] Embodiment 2, integrin binding experiment

[0073] Preparation of GST and Fc fusion protein

[0074] The nucleotide sequence encoding LLG-C4 was obtained by containing a BamHI site (5' AGGCTCGAGGATCCTCGGCC

[0075] GACGGGGCT3') and EcoRI site (5'AGGTCTAGAATTCGCCCCAGCGGCCCC3') primers were obtained by PCR amplification of phage DNA. The PCR product was purified on an agarose gel and digested with two restriction enzymes, then ligated to the PGEX-2TK vector (Amersham Phannacia Biotech, Uppsala, Sweden). Recombinants expressing LLG-C4-GST were confirmed by DNA sequencing. LLG-C4-GST was produced in E. coli strain BL21 and the product was purified by glutathione affinity chromatography followed by dialysis. An ICAM-1-Fc fusion protein containing five ICAM-1 Ig domains was produced in CHO cells and purified by protein A affinity chromatography. About 20 mg of LLG-C4-GST was produced, and its purity reached more than 95% as analyzed by SDS gel electrophoresis on a PhastSyst...

Embodiment 3

[0082] Example 3. Cell Culture and Adhesion of Cell Lines to Nonapeptide Ligands

[0083] Jurkat T-cell leukemia (ATCC no.TIB-152), U-937 histiocytic lymphoma (no.CRL-1593.2) and K562 erythroleukemia (no.45507) cell lines were maintained in RPMI 1640 medium, in which Added 2mM glutamic acid, 10mM HEPES, 1mM sodium pyruvate, penicillin (100U / ml), streptomycin (100μg / ml) and 10% fetal calf serum (FCS). THP-1 monocytic leukemia cells (ATCC TIB-202) were cultured in the same medium additionally containing 0.05 mM 2-mercaptoethanol. The nonleukocyte cell lines Eahy926, HT1080, KS6717 and SKOV-3 were cultured as previously described (Koivunen et al., 1999). T cells were isolated from the buffy coat of blood by Ficoll-Hypaque centrifugation after passing through a nylon column (Valmu and Gahmberg, 1995). Wild-type murine L929 cells and α X beta 2 Integrin-transfected L-cell lines were obtained from Dr. Y. van Kooyk (University Hospital, Nijmegen, NL)

[0084] cell adhesion

[0...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention relates to novel peptides which are useful as antagonists of the [beta]>2< integrins, to pharmaceutical compositions comprising these peptides, to the use of the novel peptides for the manufacture of pharmaceutical compositions for the treatment of inflammatory diseases and human leukemias and for inhibiting leukocyte cell adhesion and migration in general, to a method for therapeutic or prophylactic treatment of inflammatory diseases and human leukemias and to the use of the novel peptides as [beta]>2< integrin antagonists for biochemical isolation and purification procedures in vitro.

Description

field of invention [0001] The present invention relates to the use as β 2 Novel peptides of integrin antagonists, pharmaceutical compositions comprising these peptides, use of novel peptides for the preparation of pharmaceutical compositions for the treatment of inflammatory diseases and human leukemia and for the general inhibition of leukocyte adhesion and migration, treatment or prevention of inflammation Disease and methods of human leukemia, and novel peptides as beta 2 Use of integrin antagonists in in vitro biochemical isolation and purification methods. Background of the invention [0002] White blood cells that migrate through the body and various lymphoid organs are essential elements of the immune system. Leukocytes circulate in the blood or lymphatics in a quiescent and less adherent state; however, when they are activated by signals from the immune system such as exposure to an immune complex or a chemokine gradient, they Integrin adhesion receptors become ac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07K7/06C12N15/09A61K38/00A61K38/08A61K45/00A61P29/00A61P35/00C07K5/08
CPCA61K38/00C07K7/06A61P29/00A61P35/00C07K5/08
Inventor厄尔基·科伊武南卡尔·G·加姆伯格
OwnerCTT CANCER TARGETING TECH